Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guohong Han

Showing results (121-130 of 200) with videos related to

Pageof 20
Sort By:
Cardiovascular and Interventional Radiology|October 24, 2014
Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single centerMingwu Li, Ming Bai, Xingshun Qi, et al.
Journal of Hepatology|October 12, 2010
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosisGuohong Han, Xingshun Qi, Chuangye He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2014
EASL- and mRECIST-evaluated responses to combination therapy of sorafenib with transarterial chemoembolization predict survival in patients with hepatocellular carcinomaLei Liu, Weijuan Wang, Hui Chen, et al.
Future Oncology (London, England)|March 9, 2013
Sorafenib in combination with transarterial chemoembolization in Chinese patients with hepatocellular carcinoma: a subgroup interim analysis of the START trialGuohong Han, Jijin Yang, Guoliang Shao, et al.
Radiology|November 13, 2012
Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single centerGuohong Han, Xingshun Qi, Wei Zhang, et al.
BMC Cancer|May 2, 2019
Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinomaEnxin Wang, Dongdong Xia, Wei Bai, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 1, 2012
Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesisXingshun Qi, Guohong Han, Chuangye He, et al.
Radiology|September 16, 2014
Antigen-loaded dendritic cell migration: MR imaging in a pancreatic carcinoma modelZhuoli Zhang, Weiguo Li, Daniele Procissi, et al.
Journal of Hepatology|March 1, 2023
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysisAntonio Guerrero, Laura Del Campo, Fabio Piscaglia, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 19, 2015
Transjugular Intrahepatic Portosystemic Shunt for Extrahepatic Portal Venous Obstruction in ChildrenYong Lv, Chuangye He, Wengang Guo, et al.
Pageof 20

Showing results (121-130 of 200) with videos related to

Sort By:
Pageof 20
Cardiovascular and Interventional Radiology|October 24, 2014
Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single centerMingwu Li, Ming Bai, Xingshun Qi, et al.
Journal of Hepatology|October 12, 2010
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosisGuohong Han, Xingshun Qi, Chuangye He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2014
EASL- and mRECIST-evaluated responses to combination therapy of sorafenib with transarterial chemoembolization predict survival in patients with hepatocellular carcinomaLei Liu, Weijuan Wang, Hui Chen, et al.
Future Oncology (London, England)|March 9, 2013
Sorafenib in combination with transarterial chemoembolization in Chinese patients with hepatocellular carcinoma: a subgroup interim analysis of the START trialGuohong Han, Jijin Yang, Guoliang Shao, et al.
Radiology|November 13, 2012
Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single centerGuohong Han, Xingshun Qi, Wei Zhang, et al.
BMC Cancer|May 2, 2019
Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinomaEnxin Wang, Dongdong Xia, Wei Bai, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 1, 2012
Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesisXingshun Qi, Guohong Han, Chuangye He, et al.
Radiology|September 16, 2014
Antigen-loaded dendritic cell migration: MR imaging in a pancreatic carcinoma modelZhuoli Zhang, Weiguo Li, Daniele Procissi, et al.
Journal of Hepatology|March 1, 2023
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysisAntonio Guerrero, Laura Del Campo, Fabio Piscaglia, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 19, 2015
Transjugular Intrahepatic Portosystemic Shunt for Extrahepatic Portal Venous Obstruction in ChildrenYong Lv, Chuangye He, Wengang Guo, et al.
Pageof 20